Cresco Labs Valuation Multiples

Cresco Labs Overview

About Cresco Labs

Cresco Labs Inc is a vertically-integrated multi-state cannabis operator in the United States licensed to cultivate, manufacture and sell retail and medical cannabis products through Sunnyside, Cresco Labs’ national dispensary brand and others. The company operates in one segment, the cultivation, manufacturing, distribution and sale of cannabis.

Founded

1990

HQ

Employees

2.9K

Website

crescolabs.com

Sectors

CannabisCannaTechViceTech

Financials (LTM)

Revenue: $647M

EBITDA: $155M

EV

$862M

Valuation Multiples

Multiples.vc

Start free trial

Cresco Labs Financials

Cresco Labs reported last 12-month revenue of $647M and EBITDA of $155M.

In the same LTM period, Cresco Labs generated $321M in gross profit, $155M in EBITDA, and had net loss of ($114M).

Cresco Labs P&L

In the most recent fiscal year, Cresco Labs reported revenue of $656M and EBITDA of $157M.

Cresco Labs expects next 12-month revenue of XXX and NTM EBITDA of XXX

Cresco Labs Stock Performance

Cresco Labs has current market cap of $327M, and enterprise value of $862M.

Cresco Labs' stock price is $0.91.

Cresco Labs Valuation Multiples

Cresco Labs trades at 1.3x EV/Revenue multiple, and 5.6x EV/EBITDA.

Cresco Labs Financial Valuation Multiples

As of April 1, 2026, Cresco Labs has market cap of $327M and EV of $862M.

Equity research analysts estimate Cresco Labs' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Cresco Labs has a P/E ratio of (2.9x).

Cresco Labs Margins & Growth Rates

Cresco Labs' revenue in the last 12 month declined by (3%).

Cresco Labs' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Cresco Labs' rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cresco Labs' rule of X is 10% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Cresco Labs Public Comps

See public comps and valuation multiples for other Cannabis comps.

Cresco Labs M&A Activity

Cresco Labs acquired XXX companies to date.

Last acquisition by Cresco Labs was on XXXXXXXX, XXXXX. Cresco Labs acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Cresco Labs Investment Activity

Cresco Labs invested in XXX companies to date.

Cresco Labs made its latest investment on XXXXXXXX, XXXXX. Cresco Labs invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).